Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering
HAMILTON, Bermuda, May 13, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa,” “we,” and “our”) announced today that it is commencing a public offering of 1,800,000 of its Class A common shares. In addition, Kiniksa expects to …